Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indomobil Multi Jasa Tbk. (IMJS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Indomobil Multi Jasa Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Indomobil Multi Jasa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Indomobil Multi Jasa Tbk. trades at Rp183 (market cap 2.02T, 2.92M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Indomobil Multi Jasa Tbk. is far larger — about 12.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Indomobil Multi Jasa Tbk. is more actively traded (2.92M versus 324K). Which is the better fit depends on your goals.

IMJSOBAT
Market Cap
2.02T166.01B
Volume
2.92M324K
Lot
29.25K3.24K
Turnover
530.02M77.68M
Average Price
181.23239.75
Value
530.02M77.68M
Indicative Equilibrium Price
183240
Indicative Equilibrium Volume
2151

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IMJS
View details
OBAT
View details

About Indomobil Multi Jasa Tbk.

PT. Indomobil Multi Jasa (the "Company") was established on December 14, 2004 as PT Multi Tambang Abadi (MTA) based on Notarial Deed No.67 of Aulia Taufani, S.H., substitute of Sutjipto, S.H.The Company's articles of assosiation has been amended several times. Based on Notarial Deed No.56 of Ir. Nanette Cahyanie Handari Adi Warsito, S.H., dated February 13, 2013 which has been approved by the Minister of Laws and Human Rights of the Republic od Indonesia in its Decision Letter No. AHU-09669.A.H.01.02. Year 2013 dated February 28, 2013, the articles of association of the Company has been amended concerning among others.

Read more on IMJS

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT